Engelskt namn:Sermaglutide
CAS No.910463-68-2
Molekylär formel:C187H291N45O59
Molekylvikt:4113.57754
Semaglutid(Ozempic) is a glucagon-like peptide-1 analogue for once-weekly subcutaneous treatment of type 2 diabetes.Semaglutide is a pharmaceutical drug which is used for the treatment of type 2 diabetes. Semaglutide has demonstrated the potential to improve the treatment of type 2 diabetes and the positive recommendation from the Advisory Committee marks an important step towards making semaglutide available to adults with type 2 diabetes in the US. Semaglutid(Ozempic), a newly once-weekly glucagon like peptide-1 (GLP-1) receptoragonist, has showed a favorable effect on glycaemic control and weight reduction in type 2 diabetes mellitus (T2DM).
Semaglutide has a chemical structure that is very similar to the hormone glucagon-like peptide 1 (GLP-1), adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.Semaglutide may help people with obesity lose weight as well.
| namn |
CAS-nr. |
namn |
CAS-nr. |
| Tymalfasin |
69440-99-9 |
Enfuvirtide (T-20) Acetat |
159519-65-0 |
| Thymopentinacetat (TP-5) |
69558-55-0 |
Angiotensin Acetate |
58-49-1 |
| Octreotide Acetate |
83150-76-9 |
Somatostatin |
51110-01-1 |
| Melanotan II-acetat |
121062-08-6 |
Vapreotidacetat |
103222-11-3 |
| Melanotan I Acetate |
75921-69-6 |
Dy norphin A (1-13) |
72957-38-1 |
| Secretin Acetate |
17034-35-4 |
Leuprolide |
53714-56-0 |
| Ornipressinacetat |
3397-23-7 |
Eledoisinacetat |
69-25-0 |
| Oxytocinacetat |
50-56-6 |
GLP-1 (7-37) Acetat |
106612-94-6 |
| Lypressinacetat |
50-57-7 |
Pramlintide |
Pramlintide |
| Nesiritideacetat |
114471-18-0 |
Aviptadilacetat |
40077-57-4 |
| Kalcitonin (Salmone) Acetat |
47931-85-1 |
Exenatidacetat |
141732-76-5 |
